SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 42 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $65,000 | -78.9% | 192,778 | -55.0% | 0.00% | – |
| Q3 2019 | $308,000 | +6.2% | 428,257 | +301.7% | 0.00% | – |
| Q1 2018 | $290,000 | +408.8% | 106,599 | +594.4% | 0.00% | – |
| Q4 2017 | $57,000 | +119.2% | 15,351 | +14.6% | 0.00% | – |
| Q3 2017 | $26,000 | -27.8% | 13,390 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | -35.7% | 13,390 | -2.1% | 0.00% | – |
| Q1 2017 | $56,000 | – | 13,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|